Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Advisory Committee Disagreement With US FDA On Approval Decisions An Increasingly Rare Event
Jan 23 2023
•
By
Derrick Gingery
FDA-advisory committee agreement was higher among priority applications compared to standard applications. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA Performance Tracker
More from Regulatory Trackers